Overdiagnosis of bone fragility in the quest to prevent hip fracture

por
Fuente
Este artículo es originalmente publicado en:
http://www.bmj.com/content/350/bmj.h2088
De

  1. Teppo LN Järvinen, professor1, 
  2. Karl Michaëlsson, professor2, 
  3. Jarkko Jokihaara, registrar3, 
  4. Gary S Collins, associate professor4, 
  5. Thomas L Perry, clinical assistant professor5, 
  6. Barbara Mintzes, senior lecturer6, 
  7. Vijaya Musini, assistant professor5, 
  8. Juan Erviti, head7, 
  9. Javier Gorricho, senior evaluation officer8, 
  10. James M Wright, professor5, 
  11. Harri Sievänen, research director9
    Todos los derechos reservados para:
    Copyright © 2015 BMJ Publishing Group Ltd
Drug treatment to prevent hip fracture is neither viable nor cost effective, argue researchers http://t.co/HnzD6GsrQU pic.twitter.com/dD300988R9

— BMJ (@bmj_company) Mayo 26, 2015